Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.33 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | CPA1 | P15085 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | TERT | O14746 | 1/20 | 0.30 |
| ▸ | MDM4 | O15151 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | CTSL | P07711 | 1/20 | 0.30 |
| ▸ | CTSB | P07858 | 1/20 | 0.30 |
| ▸ | SLC25A21 | Q9BQT8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11666761 | 0.80 | TRPA1 (0.35) | TRPA1ALDH1A1CYP3A4HPGDALOX15 | |
| SCHEMBL173836 | 0.78 | — | — | |
| SCHEMBL5526590 | 0.76 | — | — | |
| SCHEMBL444402 | 0.76 | — | — | |
| SCHEMBL10714605 | 0.76 | TRPA1 (0.32) | TRPA1ALDH1A1CYP3A4HPGDALOX15 | |
| SCHEMBL11543482 | 0.76 | — | — | |
| SCHEMBL8596276 | 0.73 | TSHR (0.36) | — | |
| SCHEMBL10260123 | 0.73 | TSHR (0.31) | TRPA1TERTMDM4TP53CTSL | |
| SCHEMBL8979305 | 0.73 | CPB1 (0.44) | ALDH1A1SMN1; SMN2CYP2C19TDP1LMNA | |
| SCHEMBL5138213 | 0.73 | HTT (0.37) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2462932-A1 | S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer | Board Of Regents, The University Of Texas System (US) | 2012-06-13 | — | — | EP | disclosed |
| EP-2420229-A1 | S-DIMETHYLARSINO-THIOSUCCINIC ACID S-DIMETHYLARSINO-2-THIOBENZOIC ACID S-(DIMETHYLARSINO) GLUTATHIONE AS TREATMENTS FOR CANCER | Board Of Regents, University Of Texas System (US) | 2012-02-22 | — | — | EP | disclosed |
| US-7619000-B2 | S-dimethylarsino-thiosuccinic acid S-dimethylarsino-2-thiobenzoic acid S-(dimethylarsino) glutathione as treatments for cancer | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2009-11-17 | — | — | US | disclosed |
| US-20080090904-A1 | S-dimethylarsino-thiosuccinic acid S-dimethylarsino-2-thiobenzoic acid S-(dimethylarsino) glutathione as treatments for cancer | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2008-04-17 | — | — | US | disclosed |
| US-20060189687-A1 | S-dimethylarsino-thiosuccinic acid S-dimethylarsino-2-thiobenzoic acid S-(dimethylarsino) glutathione as treatments for cancer | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2006-08-24 | — | — | US | disclosed |
| EP-1474128-A4 | S-DIMETHYLARSINO-THIOSUCCINIC ACID S-DIMETHYLARSINO-2-THIOBENZOIC ACID S-(DIMETHYLARSINO) GLUTATHIONE AS TREATMENTS FOR CANCER | UNIV TEXAS (US) | 2006-05-03 | — | — | EP | disclosed |
| US-6995188-B2 | S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2006-02-07 | — | — | US | disclosed |
| US-6911471-B2 | S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2005-06-28 | — | — | US | disclosed |
| US-20050131062-A1 | S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2005-06-16 | — | — | US | disclosed |
| EP-1474128-A2 | S−DIMETHYLARSINO−THIOSUCCINIC ACID S−DIMETHYLARSINO−2−THIOBENZOIC ACID S−(DIMETHYLARSINO) GLUTATHIONE AS TREATMENTS FOR CANCER | BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM (US) | 2004-11-10 | — | — | EP | disclosed |
| US-20040034095-A1 | S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2004-02-19 | — | — | US | disclosed |
| WO-2003057012-A2 | S-DIMETHYLARSINO-THIOSUCCINIC ACID S-DIMETHYLARSINO-2-THIOBENZOIC ACID S-(DIMETHYLARSINO) GLUTATHIONE AS TREATMENTS FOR CANCER | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2003-07-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050131062-A1 | S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer | AS3MT, GSTA1, GSTM1 | TRPA1 1694/4885ALDH1A1 603/4885CYP3A4 981/4885 |
| US-20060189687-A1 | S-dimethylarsino-thiosuccinic acid S-dimethylarsino-2-thiobenzoic acid S-(dimethylarsino) glutathione as treatments for cancer | AS3MT, GSTA1, GSTM1 | TRPA1 1694/4885ALDH1A1 603/4885CYP3A4 981/4885 |
| US-20040034095-A1 | S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer | AS3MT, GSTA1, GSTM1 | TRPA1 1694/4885ALDH1A1 603/4885CYP3A4 981/4885 |
| US-20080090904-A1 | S-dimethylarsino-thiosuccinic acid S-dimethylarsino-2-thiobenzoic acid S-(dimethylarsino) glutathione as treatments for cancer | AS3MT, GSTA1, GSTM1 | TRPA1 1694/4885ALDH1A1 603/4885CYP3A4 981/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.